You are here: Industry Insights > Cell therapies

News List

Kuur Therapeutics launches to develop and commercialise off-the-shelf CAR-NKT cell therapies pharmaceutical-business-review
March 12, 2020
Kuur Therapeutics announced the launch of its new business in partnership with Baylor College of Medicine and Baylor’s Center for Cell and Gene Therapy.
GSK, Immatics team up for cancer cell therapies pharmatimes
March 10, 2020
Immatics Biotechnologies has announced a new strategic collaboration with GlaxoSmithKline (GSK), in order to develop novel adoptive cell therapies targeting multiple cancer indications.
Avectas, CCRM Enter Cell Therapy Tie-up contractpharma
March 04, 2020
Collaboration to accelerate development of novel technology for cell therapies.
Kite to open new manufacturing plant for cell therapies pharmaceutical-technology
July 18, 2019
Gilead Sciences subsidiary Kite Therapeutics will build a new facility in Oceanside, California, US, to develop and manufacture viral vectors, a key material in cell therapies production.
bluebird bio’s Analyst Day Highlights Commercial Path to Patients and Research Engine Focused on Next-Generation Gene and Cell Therapies firstwordpharma
May 10, 2019
New Collaboration with Seattle Children's Research Institute Targets New Immunotherapy Approaches to Acute Myeloid Leukemia
Pall Enters Cell and Gene Therapy Mfg. Tie-up with NJII contractpharma
March 20, 2019
New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology (NJIT) Corporation, has signed an Industry Participation Agreement with Pall Corporation to support the development of its BioPharmaceutical Innovation iLab.
Sheba, Lonza Collaborate on Cell Therapy Mfg. Platform contractpharma
March 19, 2019
Will assess automated CAR-T cell therapy manufacturing at the point-of-care.
Autolus taps Vineti to help deliver personalized cell therapies fiercebiotech
February 26, 2019
Autolus has a lot of CAR-T candidates heading for clinical trials and has teamed up with software company Vineti to try to bring them to market more efficiently....
Orgenesis Collaborates with MangoGen Pharma for Advanced Gene Delivery Platform contractpharma
December 27, 2018
Orgenesis Inc., a developer, manufacturer and service provider of advanced cell therapies, has formed a collaboration with MangoGen Pharmainitially focused on the pre-clinical development of insulin..
Nearly 300 gene and cell therapies in development – report pharmaphorum
December 10, 2018
Pharma is becoming increasingly focused on gene and cell therapies, with nearly 300 in clinical development or awaiting review by the FDA, according to a new report from US trade body PhRMA.

Previous page 1 2 3 Next page